These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9181655)

  • 21. Antibiotic therapy for acute uncomplicated pyelonephritis in women. Take resistance into account.
    Prescrire Int; 2014 Dec; 23(155):296-300. PubMed ID: 25629148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
    Sieger B; Berman SJ; Geckler RW; Farkas SA
    Crit Care Med; 1997 Oct; 25(10):1663-70. PubMed ID: 9377880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
    Duma RJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():303-9. PubMed ID: 6296025
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prospective, randomized, comparative study of the efficacy, safety and cost of cefuroxime versus cephradine in acute pyelonephritis during pregnancy].
    Ovalle A; Martínez MA; Wolff M; Cona E; Valderrama O; Villablanca E; Lobos L
    Rev Med Chil; 2000 Jul; 128(7):749-57. PubMed ID: 11050836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
    O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
    Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
    Arich C; Gouby A; Bengler C; Ardilouze JL; Dubois A; Joubert P; Hansel S; Janbon C; Fabre S
    Pathol Biol (Paris); 1987 May; 35(5):613-5. PubMed ID: 3302868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: teicoplanin plus tobramycin versus cephalothin plus tobramycin.
    Lupo A; Rugiu C; Bernich P; Laudon A; Marcantoni C; Mosconi G; Cantaluppi MC; Maschio G
    J Antimicrob Chemother; 1997 Nov; 40(5):729-32. PubMed ID: 9421325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
    Moore RD; Smith CR; Holloway JJ; Lietman PS
    Arch Intern Med; 1986 Jun; 146(6):1153-7. PubMed ID: 3087307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial.
    Torfoss D; Høiby EA; Tangen JM; Holte H; Bø K; Meyer P; Grøttum K; Weyde K; Lauritzsen GF; Sandstad B; Jacobsen AB; Olsen H; Kvaløy S
    J Antimicrob Chemother; 2007 Apr; 59(4):711-7. PubMed ID: 17327294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empiric treatment of serious infections in patients with cancer: randomised comparison of two combinations.
    Maiche AG; Teerenhovi L
    Infection; 1991; 19 Suppl 6():S326-9. PubMed ID: 1791078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department.
    Park KH; Oh WS; Kim ES; Park SW; Hur JA; Kim YK; Moon C; Lee JH; Lee CS; Kim BN
    Int J Infect Dis; 2014 Jun; 23():8-13. PubMed ID: 24657271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical efficacy of the antimicrobial drug furamag in nosocomial urinary tract infections].
    Iakovlev SV; Suvorova MP; Kolendo SE; Burmistrova EN; Sergeeva EV; Cherkasova NA; Eremina LV
    Ter Arkh; 2014; 86(10):65-72. PubMed ID: 25509895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An antibiotic policy to prevent emergence of resistant bacilli.
    de Man P; Verhoeven BA; Verbrugh HA; Vos MC; van den Anker JN
    Lancet; 2000 Mar; 355(9208):973-8. PubMed ID: 10768436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
    Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA
    JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotics for acute pyelonephritis in children.
    Bloomfield P; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2003; (3):CD003772. PubMed ID: 12917987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patients.
    Hobbs AL; Shea KM; Daley MJ; Huth RG; Jaso TC; Bissett J; Hemmige V
    J Antimicrob Chemother; 2016 Jun; 71(6):1665-71. PubMed ID: 26983859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats.
    Marre R; Herhahn D; Schulz E; Freiesleben H; Sack K
    Infection; 1983; 11 Suppl 1():S54-6. PubMed ID: 6299968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the efficacy and tolerance of a short 7 day third-generation cephalosporin treatment in the management of acute pyelonephritis in young women in the emergency department.
    Moustafa F; Nguyen G; Mathevon T; Baud O; Saint-Denis J; Dublanchet N; Pereira B; Shinjo C; Romaszko JP; Dopeux L; Dutheil F; Schmidt J
    J Antimicrob Chemother; 2016 Jun; 71(6):1660-4. PubMed ID: 26903277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
    Smith CR; Ambinder R; Lipsky JJ; Petty BG; Israel E; Levitt R; Mellits ED; Rocco L; Longstreth J; Lietman PS
    Ann Intern Med; 1984 Oct; 101(4):469-77. PubMed ID: 6089633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.